Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Matrix Capital Management (C)
Baker, Malcolm P.; Lane, DavidCaso HBS-211060-EFinanzasBen Balbale, a partner at hedge fund Matrix Capital, must decide whether to exit their investment in Rovi Corporation, a company with a diverse portfolio of patents used primarily for digital interactive guides. Rovi's shares are up over 50% from the time Balbale initiated a position in the middle of 2009.Desde 5,74 €
-
Matrix Capital Management (B)
Baker, Malcolm P.; Lane, DavidCaso HBS-211048-EFinanzasBen Balbale, a partner at hedge fund Matrix Capital, must decide whether to exit their investment in Rovi Corporation, a company with a diverse portfolio of patents used primarily for digital interactive guides. Rovi's shares are up over 50% from the time Balbale initiated a position in the middle of 2009.Desde 5,74 €
-
Matrix Capital Management (A)
Baker, Malcolm P.; Lane, DavidCaso HBS-211017-EFinanzasBen Balbale, a partner at hedge fund Matrix Capital, must decide whether to exit their investment in Rovi Corporation, a company with a diverse portfolio of patents used primarily for digital interactive guides. Rovi's shares are up over 50% from the time Balbale initiated a position in the middle of 2009.Desde 8,20 €
-
Cost of Capital at DraftKings
Baker, Malcolm P.; Hillenbrand, Sebastian; Barnett, JamesCaso HBS-224007-EFinanzasDesde 8,20 €
-
Supply Chain Finance at Procter & Gamble
Esty, Benjamin C.; Mayfield, E. Scott; Lane, DavidCaso HBS-216039-EFinanzasIn April 2013, Procter & Gamble (P&G), the world's largest consumer packaged goods (CPG) company, announced that it would extend its payment terms to suppliers by 30 days. At the same time, P&G announced a new supply chain financing (SCF) program giving sDesde 8,20 €
-
Bayer Crop Science
Bell, David E.; McLoughlin, Damien P.; Kindred, Natalie; Barnett, JamesCaso HBS-520055-EDirección estratégicaIn mid-2019, a year after German conglomerate Bayer Group closed its acquisition of U.S.-based seeds giant Monsanto, the leadership of Bayer's Crop Science division (which absorbed Monsanto) is reflecting on the opportunities ahead. Some observers have questioned Bayer's decision to buy Monsanto, citing potential reputational and financial liabilities; in the last year, Bayer's stock price has suffered. However, the leadership team expects the co...Desde 8,20 €